CLINICAL_TRIALS
trial_result
· 2022-07-19
Clinical Trial Update: Patients Receiving Induction With Liposomal Daunorubicin and Cytarabine (CPX-351) for Acute Myeloid Leukemia [Phase 4]
Summary
Phase 4 clinical trial update for CPX-351 (liposomal daunorubicin and cytarabine) in acute myeloid leukemia; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medical College of Wisconsin | Conditions: Leukemia, Myeloid, Acute | Phase 4 | Status: TERMINATED | Results posted: 2022-07-19